Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Published:2018-08 Issue: Volume:Volume 10 Page:3083-3099
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Rocca Andrea^ORCID,Maltoni Roberta,Bravaccini Sara^ORCID,Donati Caterina^ORCID,Andreis Daniele

Publisher

Informa UK Limited

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secosteroid diacylhydrazines as novel effective agents against hormone-dependent breast cancer cells;The Journal of Steroid Biochemistry and Molecular Biology;2024-11

2. Estrogen Receptor Blockade Potentiates Immunotherapy for Liver Metastases by Altering the Liver Immunosuppressive Microenvironment;Cancer Research Communications;2024-08-01

3. Injectable Hydrogels for Intratumoral Administration Against Breast Cancer;Journal of Polymers and the Environment;2024-07-09

4. TNFR1/p38αMAPK signaling in Nex + supraspinal neurons regulates estrogen-dependent chronic neuropathic pain;Brain, Behavior, and Immunity;2024-07

5. Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP